Gland Pharma Limited — Metoclopramide Exporter Profile
Indian Pharmaceutical Exporter · #9 for Metoclopramide · $286.0K export value · DGFT Verified
Gland Pharma Limited is the #9 Indian exporter of Metoclopramide with $286.0K in export value and 20 verified shipments. Gland Pharma Limited holds a 1.3% market share in Metoclopramide exports across 3 countries. The company exports 29 pharmaceutical products worth $262.0M across 15 therapeutic categories.
Gland Pharma Limited — Metoclopramide Export Profile: Buyers & Destinations
Where Does Gland Pharma Limited Export Metoclopramide?
| Country | Value | Shipments | Share |
|---|---|---|---|
| IRAQ | $142.3K | 11 | 47.6% |
| UNITED ARAB EMIRATES | $86.5K | 9 | 28.9% |
| NETHERLANDS | $70.3K | 6 | 23.5% |
Gland Pharma Limited exports Metoclopramide to 3 countries. The largest destination is IRAQ accounting for 47.6% of Gland Pharma Limited's Metoclopramide shipments, followed by UNITED ARAB EMIRATES (28.9%) and NETHERLANDS (23.5%). These destinations reflect Gland Pharma Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Metoclopramide from Gland Pharma Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| AL-RAZAN DRUGS SCIENTIFIC BUREAU | IRAQ | $73.4K | 8 |
| IDA TRADING MEA C/O KUEHNE + NAGEL | UNITED ARAB EMIRATES | $72.9K | 7 |
| AL RAZAN DRUGS SCIENTIFIC BUREAU | IRAQ | $68.9K | 3 |
| IMRES B.V. | NETHERLANDS | $36.7K | 3 |
| IDA FOUNDATION-WHS TILBURG D300T | NETHERLANDS | $20.1K | 2 |
| IMRES B.V | NETHERLANDS | $13.5K | 1 |
| IDA TRADING MEA | UNITED ARAB EMIRATES | $10.1K | 1 |
| IMPERIAL MEDICAL SOLUTIONS FZE | UNITED ARAB EMIRATES | $3.5K | 1 |
Gland Pharma Limited supplies Metoclopramide to 8 buyers globally. The largest buyer is AL-RAZAN DRUGS SCIENTIFIC BUREAU (IRAQ), followed by IDA TRADING MEA C/O KUEHNE + NAGEL (UNITED ARAB EMIRATES) and AL RAZAN DRUGS SCIENTIFIC BUREAU (IRAQ). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Metoclopramide Export Value and How Much Does Gland Pharma Limited Contribute?
India exported $11.2M worth of Metoclopramide through 2,053 shipments from 321 suppliers to 126 countries, serving 568 buyers globally. Gland Pharma Limited contributes $286.0K to this total, accounting for 1.3% of India's Metoclopramide exports. Gland Pharma Limited ships Metoclopramide to 3 countries through 8 buyers.
What Is the Average Shipment Value for Gland Pharma Limited's Metoclopramide Exports?
Gland Pharma Limited's average Metoclopramide shipment value is $14.3K per consignment, based on 20 shipments totaling $286.0K. The largest destination is IRAQ (47.6% of Gland Pharma Limited's Metoclopramide exports).
How Does Gland Pharma Limited Compare to Other Indian Metoclopramide Exporters?
Gland Pharma Limited ranks #9 among 321 Indian Metoclopramide exporters with a 1.3% market share. The top 3 exporters are IPCA LABORATORIES LIMITED ($5.1M), AVET LIFESCIENCES PRIVATE LIMITED ($1.5M), BAXTER PHARMACEUTICALS INDIA PRIVATE LIMITED ($947.6K). Gland Pharma Limited processed 20 shipments to 3 destination countries.
What Metoclopramide Formulations Does Gland Pharma Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| METOCLOPRAMIDE INJECTION BP 5MG/ML,2ML A | $54.8K | 6 |
| METOCLOPRAMIDE INJECTIOIN 10MG/2ML (5MG/ | $52.9K | 5 |
| METOCLOPRAMIDE INJECTION BP 5MG ML 2MLAMPOULE | $50.0K | 1 |
| METOCLOPRAMIDE HCL 10MG/2ML INJ (5MG/ML) | $26.8K | 2 |
| METOCLOPRAMIDE INJECTION 10MG/2ML (5MG/M | $20.1K | 2 |
| METOCLOPRAMIDE INJECTIOIN 10MG/2ML (5MG/ML) | $19.9K | 2 |
| METOCLOPRAMIDE HCL 5MG/MLINJECTION 2ML A | $13.5K | 1 |
| METOCLOPRAMIDE HCL 5MG/MLINJECTION 2ML AMPS | $13.4K | 2 |
| METOCLOPRAMIDE INJECTIOIN 10MG/2ML 5MG/ML | $10.1K | 1 |
| METOCLOPRAMIDE INJECTION BP 5MG/ML,2ML AMPOULE | $9.6K | 1 |
Gland Pharma Limited exports 13 distinct Metoclopramide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is METOCLOPRAMIDE INJECTION BP 5MG/ML,2ML A with 6 shipments worth $54.8K.
How Does Gland Pharma Limited Compare to Nearest Metoclopramide Exporters?
Exporters ranked immediately above and below #9 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 7 | SCOTT EDIL PHARMACIA LIMITED | $343.9K | 44 | 9 | $7.8K |
| 8 | CADILA PHARMACEUTICALS LIMITED | $336.3K | 8 | 1 | $42.0K |
| 9 | GLAND PHARMA LIMITED ★ | $286.0K | 20 | 3 | $14.3K |
| 10 | MAIVA PHARMA PRIVATE LIMITED | $229.4K | 5 | 3 | $45.9K |
| 11 | INTAS PHARMACEUTICALS LIMITED | $215.4K | 39 | 3 | $5.5K |
Gland Pharma Limited ranks #9 among 321 Indian Metoclopramide exporters. Average shipment value of $14.3K compared to the market average of $34.8K. The closest competitors by value are SCOTT EDIL PHARMACIA LIMITED and CADILA PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Metoclopramide Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 264 | 12.9% |
| SAHAR AIR | 223 | 10.9% |
| SAHAR AIR CARGO ACC (INBOM4) | 199 | 9.7% |
| DELHI AIR CARGO ACC (INDEL4) | 147 | 7.2% |
| JNPT/ NHAVA SHEVA SEA | 120 | 5.8% |
| DELHI AIR | 87 | 4.2% |
| JNPT | 80 | 3.9% |
| AHEMDABAD ICD | 80 | 3.9% |
What Other Gastrointestinal Products Does Gland Pharma Limited Export?
Gland Pharma Limited also exports these gastrointestinal products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Gland Pharma Limited's Metoclopramide Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Gland Pharma. The Israel-Iran tensions have led to increased security risks in the Red Sea, prompting major shipping lines to implement 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU. This escalation in shipping costs directly impacts the profitability of exports to Europe and the U.S. East Coast, necessitating strategic adjustments in logistics and pricing strategies. (sgeexport.com)
Conversely, the India–European Union Free Trade Agreement (FTA), concluded on January 27, 2026, offers a favorable outlook. The agreement eliminates tariffs on most European optical, medical, surgical, and pharmaceutical exports to India, and vice versa, potentially enhancing Gland Pharma's competitiveness in the European market. This development aligns with the company's strategic objectives to deepen market penetration and increase market share within existing therapeutic areas. (en.wikipedia.org)
Gland Pharma Limited — Regulatory Compliance & Quality Standards
Maintaining compliance with international regulatory standards is paramount for Gland Pharma's export operations. The company's Visakhapatnam facility's recent EIR from the USFDA underscores its commitment to quality and regulatory adherence. (business-standard.com) Additionally, the Danish Medicines Agency's Good Manufacturing Practice (GMP) compliance certification for Gland Pharma's facility further validates its manufacturing excellence. (ainvest.com)
However, challenges persist, as evidenced by the French drug regulator ANSM's issuance of ten observations to Gland Pharma's subsidiary, Cenexi, following a GMP inspection. The company is actively addressing these observations, reflecting its proactive approach to regulatory compliance and continuous improvement. (business-standard.com)
About Gland Pharma Limited
Gland Pharma Limited exports 29 products worth $262.0M. Beyond Metoclopramide, top products include Heparin, Enoxaparin, Syringe, Ketorolac, Sodium. View the complete Gland Pharma Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Metoclopramide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Metoclopramide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Gland Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 26 individual customs records matching Gland Pharma Limited exporting Metoclopramide, covering 13 formulations to 3 countries via 8 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 126+ countries, 568+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Metoclopramide Export Data from Gland Pharma Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Gland Pharma Limited's Metoclopramide exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Gland Pharma Limited
Full Company Profile →
29 products · $262.0M total trade · 15 categories
Metoclopramide Stats
Company Overview
Top Products by Gland Pharma Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Gland Pharma Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Metoclopramide. For current shipment-level data, contact TransData Nexus.